Purchase Order 75N94019P00576
- Not listed
- This federal contract award was made by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $4,385.32 firm fixed-price purchase order is for gene synthesis services to support NICHD's research activities. The contract does not have a set-aside designation. Genscript USA Inc. is a for-profit organization that has...
- This federal contract award to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, is for the provision of a wide range of molecular biology products and services to support biomedical research and public health initiatives. The $19,395.39 firm fixed-price purchase order contract, awarded by the National Institute of Child Health and Human Development (NICHD), covers gene synthesis, cloning, protein expression and purification, antibody production, and other...
- This federal contract award from the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services, is for a Firm Fixed Price Purchase Order with Genscript USA Inc. to provide "STABLE RESEARCH CELL LINE SERVICE, INCLUDES SHIPPING CHARGES". The contract has a ceiling value of $9,885.25 and an ultimate completion date of February 28, 2011. Genscript USA Inc. is a biotechnology company that specializes in supplying...
- This federal contract award, valued at $4,367.10, was issued by the National Institute of Child Health and Human Development (NICHD) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for a firm fixed-price purchase order with a completion date of September 30, 2014. Genscript, which operates as a for-profit organization, has received numerous prime and subcontract awards from various Department of Health and Human Services (HHS) agencies, including...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), which is part of the Department of Health and Human Services (HHS). The contract was awarded to Genscript USA Inc., a small business biotechnology company based in Piscataway, New Jersey, for $11,434.95. The contract has an ultimate completion date of July 30, 2025. Genscript specializes in gene synthesis, gene editing, custom protein and antibody production, and other...
- This federal contract award to Genscript USA Inc., a biotechnology company based in New Jersey, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,196.16 firm fixed-price purchase order is for gene synthesis services. Genscript, a for-profit organization, has a history of providing a wide range of molecular biology products and services to...
- This federal contract award, valued at $4,263.55, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in New Jersey. The contract is for the provision of various molecular biology products and services, including gene synthesis, gene editing, custom protein and antibody production, to support biomedical research and public health initiatives. While...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,342.69 firm fixed-price purchase order was awarded to Genscript USA Inc., a biotechnology company based in New Jersey, for gene synthesis and plasmid preparation services. The contract did not have a set-aside designation. Genscript has received numerous prime and...
- This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $10,982.04 contract is for the provision of customized protein services, gene synthesis, and other molecular biology products and services to support biomedical research and public health initiatives. The contract does not...
- This federal contract award to Genscript USA Inc., a biotechnology company, was issued by the National Cancer Institute, which is part of the Department of Health and Human Services' National Institutes of Health. The $17,250.82 firm fixed price purchase order is for the provision of biological products and services, with a completion date of June 26, 2024. Genscript has previously received other prime federal contracts to supply customized DNA, antibodies, proteins, and other materials for...
This federal contract award, valued at $24,999.00, was issued by the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in New Jersey. The contract requires Genscript to generate four stable cell lines, with a final completion date of March 11, 2022. This was a firm fixed-price purchase order, and there was no set-aside designation. Genscript has received numerous prime and subcontract awards from HHS agencies, including the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA), as well as the U.S. Department of Agriculture (USDA). These contracts typically involve supplying customized DNA constructs, antibodies, proteins, cell lines, and related services to support biomedical research and public health initiatives, including efforts to address emerging infectious disease threats like COVID-19, influenza, HIV, and Ebola.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 3/11/22 | |
| Not listed | Not listed | $25.0k | 7/16/19 |